Qianrong Zheng

Wenzhou, 325000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

LCZ696 (Sac/Val) protects against high-fat diet-induced kidney injury in mice by targeting ROCK2 to suppress ROCK2/NF-κB signaling.

LCZ696 (Sac/Val) protects against high-fat diet-induced kidney injury in mice by targeting ROCK2 to suppress ROCK2/NF-κB signaling.

Journal: Cellular signalling

Published: December 05, 2025

Predicting Stroke Incidence Using Estimated Glucose Disposal Rate Index in the Population with Cardiovascular-Kidney-Metabolic Syndrome Stage 0-3 in the Chinese Middle-Aged and Elderly Population.

Predicting Stroke Incidence Using Estimated Glucose Disposal Rate Index in the Population with Cardiovascular-Kidney-Metabolic Syndrome Stage 0-3 in the Chinese Middle-Aged and Elderly Population.

Journal: Cardiorenal medicine

Published: August 15, 2025

Salvianolic Acid A Protects Against Angiotensin II-Induced Hypertensive Kidney Disease by Targeting TLR4 and Inhibiting TLR4/Myd88/PI3K/AKT/NF-κB Pathway.

Salvianolic Acid A Protects Against Angiotensin II-Induced Hypertensive Kidney Disease by Targeting TLR4 and Inhibiting TLR4/Myd88/PI3K/AKT/NF-κB Pathway.

Journal: Molecular nutrition & food research

Published: July 20, 2025

Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome.

Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome.

Journal: Cardiovascular diabetology

Published: March 10, 2025

Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3.

Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3.

Journal: JACC. Advances

Published: February 12, 2025

Association between atherogenic index of plasma and all-cause mortality and cardiovascular disease among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.

Association between atherogenic index of plasma and all-cause mortality and cardiovascular disease among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.

Journal: Diabetology & metabolic syndrome

Published: January 08, 2025

Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Journal: Cardiovascular diabetology

Published: November 08, 2024

Association between estimated glucose disposal rate control level and stroke incidence in middle-aged and elderly adults.

Association between estimated glucose disposal rate control level and stroke incidence in middle-aged and elderly adults.

Journal: Journal of diabetes

Published: February 27, 2024

Showing 1-8 of 8

Last Updated: 09/26/2026